MedTrace Logo

Second Enhanced Control of Hypertension and Thrombectomy Stroke Study (ENCHANTED2)

NCT04140110 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 816

Last updated 2023-09-13

No results posted yet for this study

Summary

ENCHANTED2 is an international, multicenter, prospective, randomised, open, blinded end-point assessed (PROBE) trial, to assess different approaches to manage blood pressure (BP) in acute ischemic stroke (AIS) patients who have undergone mechanical thrombectomy (MT). There are two nested substudies evaluating different approaches to secondary prevention in this high-risk stroke population.

Conditions

  • Acute Ischemic Stroke

Interventions

OTHER

Intensive BP lowering

The aim is to achieve a systolic BP level of \<120mmHg within 1 hour after randomisation and to maintain this BP level for the next 72 hours (or until hospital discharge or death if this should occur earlier).

Sponsors & Collaborators

  • Changhai Hospital

    collaborator OTHER

  • The George Institute for Global Health, China

    lead OTHER

Principal Investigators

  • Craig Anderson · The George Institute for Global Health, China

  • Jianmin Liu · Changhai Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-20
Primary Completion
2022-07-15
Completion
2022-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04140110 on ClinicalTrials.gov